Följande ytterligare biverkningar har rapporterats sedan irbesartan introducerades på marknaden; dessa baseras på spontana rapporter, där frekvens inte kan bestämmas: ###>The following additional adverse reactions have been reported during post– marketing experience; they are derived from spontaneous reports for which incidences cannot be determined: